BUSINESS BRIEFING
- Share via
Times Wire Reports
Amgen Inc. said its cancer drug Vectibix was effective for treatment of advanced colon cancer, a result that could help signal a comeback for the biotechnology company’s first tumor-fighting drug.
A late-stage study found that Vectibix, introduced in 2006 as a cancer treatment, “significantly prolonged” the time before symptoms worsened in advanced colon cancer patients with certain gene mutations, the Thousand Oaks company said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
